Sponsor Pipeline

Hummingbird Bioscience Clinical Trial Pipeline

Data updated daily from ClinicalTrials.gov — last refresh 2026-08-16
3
Active Trials
2
Recruiting
6
Disease Areas
Active Trials by Phase
Phase 1/2
2
Phase 1
1
Active Trials
NCT IDTitleConditionStatus
Phase 1/2
NCT06956690 A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and… Melanoma (Skin) Recruiting
NCT05910827 A Phase Ib/II Study of an Anti-HER3 Antibody, HMBD-001, With Cetuximab +/- Docetaxel in… Advanced or Metastatic Squamous Non-Small Cell Lung Cancer Recruiting
Phase 1
NCT05919537 Study of an Anti-HER3 Antibody, HMBD-001, With or Without Chemotherapy in Patients With… Non-Small Cell Lung Cancer Active, Not Recruiting
Disease Areas
Non-Small Cell Lung Cancer (NSCLC) (3) Lung Cancer (3) Head & Neck Cancer (1) Pancreatic Cancer (1) Breast Cancer (1) Melanoma (1)
Get alerts when Hummingbird Bioscience's trials change
Status changes, date slips, and new filings — detected daily, delivered to your inbox.
Start monitoring free